Product Details for: Amjevita

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
20MG/0.4ML
Pre-Filled Syringe
351(k) Interchangeable
Amjevita
Rx
002
Injection
Subcutaneous
40MG/0.8ML
Pre-Filled Syringe
351(k) Interchangeable
Amjevita
Rx
003
Injection
Subcutaneous
40MG/0.8ML
Autoinjector
351(k) Interchangeable
Amjevita
Rx
004
Injection
Subcutaneous
10MG/0.2ML
Pre-Filled Syringe
351(k) Interchangeable
Amjevita
Rx
005
Injection
Subcutaneous
20MG/0.2ML
Pre-Filled Syringe
351(k) Interchangeable
Amjevita
Rx
006
Injection
Subcutaneous
40MG/0.4ML
Pre-Filled Syringe
351(k) Interchangeable
Amjevita
Rx
007
Injection
Subcutaneous
80MG/0.8ML
Pre-Filled Syringe
351(k) Interchangeable
Amjevita
Rx
008
Injection
Subcutaneous
40MG/0.4ML
Autoinjector
351(k) Interchangeable
Amjevita
Rx
009
Injection
Subcutaneous
80MG/0.8ML
Autoinjector
351(k) Interchangeable
Amjevita
Rx
Proper Name
adalimumab-atto
Reference Product Proper Name
adalimumab
Reference Product Properietary Name
Humira
BLA Number
761024
Applicant
Amgen Inc.
Original Approval Date
September 23, 2016
Date of First Licensure
RETURN TO SEARCH RESULTS